Team:Oxford/P&P public engagement
From 2014.igem.org
(Difference between revisions)
Olivervince (Talk | contribs) |
Olivervince (Talk | contribs) |
||
Line 1: | Line 1: | ||
<html> | <html> | ||
<head> | <head> | ||
- | |||
<style type="text/css"> | <style type="text/css"> | ||
@import url(http://fonts.googleapis.com/css?family=PT+Serif|Open+Sans:300italic,400,300); | @import url(http://fonts.googleapis.com/css?family=PT+Serif|Open+Sans:300italic,400,300); | ||
- | |||
html, body { | html, body { | ||
max-width: 100%; | max-width: 100%; | ||
Line 142: | Line 140: | ||
display: block; | display: block; | ||
} | } | ||
+ | |||
+ | .heading { | ||
+ | -webkit-transition: margin-left 0.3s, -webkit-transform 0.3s; | ||
+ | transition: margin-left 0.3s; | ||
+ | } | ||
+ | |||
+ | .heading:hover { | ||
+ | margin-left:30px; | ||
+ | } | ||
Line 159: | Line 166: | ||
.pink_news_block { | .pink_news_block { | ||
- | background: # | + | background: #DEA5A4; |
border-radius:15px; margin-top:2%; padding-left:2%;padding-right:2%;padding-top:3%;padding-bottom:3%; | border-radius:15px; margin-top:2%; padding-left:2%;padding-right:2%;padding-top:3%;padding-bottom:3%; | ||
width:96%; | width:96%; | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
} | } | ||
Line 201: | Line 196: | ||
background: #FFFF06; | background: #FFFF06; | ||
border-radius:30px; margin-top:2%; padding-left:2%;padding-right:2%;padding-top:2%;padding-bottom:2%; | border-radius:30px; margin-top:2%; padding-left:2%;padding-right:2%;padding-top:2%;padding-bottom:2%; | ||
- | width: | + | width:100%; |
} | } | ||
.white_news_block { | .white_news_block { | ||
Line 215: | Line 210: | ||
font-family:Helvetica; | font-family:Helvetica; | ||
margin-bottom: 2%; | margin-bottom: 2%; | ||
- | |||
} | } | ||
Line 223: | Line 217: | ||
font-family:Helvetica; | font-family:Helvetica; | ||
color:#fff; | color:#fff; | ||
- | |||
} | } | ||
h1blue { | h1blue { | ||
Line 254: | Line 247: | ||
line-height:150%; | line-height:150%; | ||
} | } | ||
- | |||
h1black { | h1black { | ||
Line 260: | Line 252: | ||
font-weight: 400; | font-weight: 400; | ||
font-family:Helvetica; | font-family:Helvetica; | ||
- | |||
} | } | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
</style> | </style> | ||
Line 339: | Line 266: | ||
+ | #list li { | ||
+ | list-style-image: url("https://static.igem.org/mediawiki/2014/6/6f/OxigemTick.png"); } | ||
+ | } | ||
+ | </style> | ||
<script type="text/javascript"> | <script type="text/javascript"> | ||
Line 349: | Line 280: | ||
$(document).ready(function(){ | $(document).ready(function(){ | ||
$("#arrowr").click(function(){ | $("#arrowr").click(function(){ | ||
- | $("#grey").animate({right:'- | + | $("#grey").animate({right:'-175px'}, "fast"); |
}); | }); | ||
- | |||
- | |||
$("#arrowl").click(function(){ | $("#arrowl").click(function(){ | ||
- | $("#grey").animate({right:'- | + | $("#grey").animate({right:'-120px'}, "fast"); |
+ | }); | ||
+ | $("#modelling").hover(function(){ | ||
+ | $("#modelling").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#modelling1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#modelling").mouseout(function(){ | ||
+ | $("#modelling").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#modelling1").css({display:'none'}); | ||
+ | }); | ||
+ | $("#achievements").hover(function(){ | ||
+ | $("#achievements").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#achievements1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#achievements").mouseout(function(){ | ||
+ | $("#achievements").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#achievements1").css({display:'none'}); | ||
+ | }); | ||
+ | $("#igemcomm").hover(function(){ | ||
+ | $("#igemcomm").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#igemcomm1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#igemcomm").mouseout(function(){ | ||
+ | $("#igemcomm").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#igemcomm1").css({display:'none'}); | ||
+ | }); | ||
+ | $("#safety").hover(function(){ | ||
+ | $("#safety").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#safety1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#safety").mouseout(function(){ | ||
+ | $("#safety").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#safety1").css({display:'none'}); | ||
+ | }); | ||
+ | $("#team").hover(function(){ | ||
+ | $("#team").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#team1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#team").mouseout(function(){ | ||
+ | $("#team").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#team1").css({display:'none'}); | ||
+ | }); | ||
+ | $("#dcmation").hover(function(){ | ||
+ | $("#dcmation").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#dcmation1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#dcmation").mouseout(function(){ | ||
+ | $("#dcmation").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#dcmation1").css({display:'none'}); | ||
+ | }); | ||
+ | $("#interlab").hover(function(){ | ||
+ | $("#interlab").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#interlab1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#interlab").mouseout(function(){ | ||
+ | $("#interlab").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#interlab1").css({display:'none'}); | ||
+ | }); | ||
+ | $("#policy").hover(function(){ | ||
+ | $("#policy").animate({opacity:'0.95'}, "fast"); | ||
+ | $("#policy1").css({display:'inline'}); | ||
+ | }); | ||
+ | $("#policy").mouseout(function(){ | ||
+ | $("#policy").animate({opacity:'0.75'}, "fast"); | ||
+ | $("#policy1").css({display:'none'}); | ||
}); | }); | ||
+ | }); | ||
+ | |||
+ | |||
+ | jQuery(document).ready(function(){ | ||
+ | jQuery('#tb1').live('click', function(event) { | ||
+ | jQuery('#b1').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#tb2').live('click', function(event) { | ||
+ | jQuery('#b2').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#tb3').live('click', function(event) { | ||
+ | jQuery('#b3').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#tb4').live('click', function(event) { | ||
+ | jQuery('#b4').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#tb5').live('click', function(event) { | ||
+ | jQuery('#b5').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#ts1').live('click', function(event) { | ||
+ | jQuery('#s1').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#ts2').live('click', function(event) { | ||
+ | jQuery('#s2').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#ts3').live('click', function(event) { | ||
+ | jQuery('#s3').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#ts4').live('click', function(event) { | ||
+ | jQuery('#s4').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#tg1').live('click', function(event) { | ||
+ | jQuery('#g1').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#tg2').live('click', function(event) { | ||
+ | jQuery('#g2').toggle('show'); | ||
+ | }); | ||
+ | jQuery('#tg3').live('click', function(event) { | ||
+ | jQuery('#g3').toggle('show'); | ||
+ | }); | ||
+ | }); | ||
+ | |||
+ | |||
+ | function startup(){ | ||
+ | $("#sidebarblue").animate({marginLeft:'+=250px'}, 1000); | ||
+ | $("#sidebarlogo").animate({marginLeft:'+=250px'}, 1000); | ||
+ | } | ||
+ | function startup1(){ | ||
+ | $(".1").animate({marginLeft:'+=250px'}, 1000); | ||
+ | } | ||
+ | function startup2(){ | ||
+ | $(".2").animate({marginLeft:'+=250px'}, 1000); | ||
+ | } | ||
+ | function startup3(){ | ||
+ | $(".3").animate({marginLeft:'+=250px'}, 1000); | ||
+ | } | ||
+ | function startup4(){ | ||
+ | $(".4").animate({marginLeft:'+=250px'}, 1000); | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | $(document).ready(function(){ | ||
+ | setTimeout(function() { | ||
+ | startup(); | ||
+ | }, 1500); | ||
+ | setTimeout(function() { | ||
+ | startup1(); | ||
+ | }, 1520); | ||
+ | setTimeout(function() { | ||
+ | startup2(); | ||
+ | }, 1560); | ||
+ | setTimeout(function() { | ||
+ | startup3(); | ||
+ | }, 1640); | ||
+ | setTimeout(function() { | ||
+ | startup4(); | ||
+ | }, 1750); | ||
}); | }); | ||
Line 374: | Line 445: | ||
<div style="background-color:#D9D9D9; opacity:0.7; z-index:5; margin-right:auto;margin-left:auto; Height:75px; width:60%;min-width:300px;font-size:65px;font-family:Helvetica;padding-top:5px; font-weight: 450;"> | <div style="background-color:#D9D9D9; opacity:0.7; z-index:5; margin-right:auto;margin-left:auto; Height:75px; width:60%;min-width:300px;font-size:65px;font-family:Helvetica;padding-top:5px; font-weight: 450;"> | ||
- | <div style="background-color:white; opacity:0.7; Height:75px; width:100%;margin-top:5px:margin-bottom:5px;min-width:300px;font-size:65px;font-family:Helvetica;padding-top:5px; color:#596C8A; font-weight: 450;"><br> | + | <div style="background-color:white; opacity:0.7; Height:75px; width:100%;margin-top:5px:margin-bottom:5px;min-width:300px;font-size:65px;font-family:Helvetica;padding-top:5px; color:#596C8A; font-weight: 450;"><br>Public Engagement</div> |
</div> | </div> | ||
<br><br> | <br><br> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<div class="white_news_block"> | <div class="white_news_block"> | ||
- | < | + | <h1blue2>Focus Groups</h1blue2> |
- | + | ||
+ | Our team hosted a group of volunteers, members of the public with no particular interest or prior experience of biotechnology. Our aim was to gain a deeper understanding of public perceptions and concerns regarding the advance of synthetic biology, and in particular to get an idea of how far these concerns are based on misinformation/lack of understanding, and how far they are legitimate, well-founded fears which need to be addressed by the scientific community as the field grows and develops. If synthetic biology is to become increasingly socially accepted, public participation in it’s growth will be essential. | ||
- | |||
- | |||
- | |||
- | |||
- | |||
</div> | </div> | ||
Line 426: | Line 467: | ||
- | |||
- | |||
- | < | + | <div class="white_news_block"> |
- | + | <h1blue2>8th August 2014 - Round 1</h1blue2> | |
- | < | + | |
- | |||
+ | Our team hosted a group of volunteers, members of the public with no particular interest or prior experience of biotechnology. Our aim was to gain a deeper understanding of public perceptions and concerns regarding the advance of synthetic biology, and in particular to get an idea of how far these concerns are based on misinformation/lack of understanding, and how far they are legitimate, well-founded fears which need to be addressed by the scientific community as the field grows and develops. | ||
+ | Particular issues which appear to be recurring themes in this discussion include: | ||
+ | <br><br> | ||
+ | - Cross-Contamination of 'engineered' genes between synthetic and natural organisms | ||
+ | There is widespread concern that biological machines may evolve, proliferate, and produce unexpected interactions which might alter the ecosystem. | ||
+ | - Use of Bacteria (such as E. coli and P. pseudomonas) | ||
+ | The notion of 'bacteria' generally, and particularly the strains our team plans to use, have strong medical associations and are believed by many to be hazardous to health. E coli is widely understood to cause diarrhea, nausea and vomiting, whilst pseudomonas is best known for causing infections including pneumonia and swimmer's ear. | ||
+ | - Uncontrolled Release of modified organisms into the environment | ||
+ | People have concerns that these will have unpredictable effects on ecosystems and that once taken these actions are difficult if not impossible to reverse. For example, synthetic organisms may outcompete their ‘natural’ counterparts and permanently damage biodiversity. | ||
+ | - Spread of Antibiotic Resistance from synthetic to natural bacteria | ||
+ | Based on vague knowledge that bacteria used in research are generally given characteristics of anti-biotic resistance and that these can spread between organisms. | ||
+ | - Bioterrorism | ||
+ | The public are fearful of the ability of synthetic biology to produce known/modified/new organisms designed to be harmful to humans (as demonstrated, for example, by the synthesis of viruses such as the polio virus and the pandemic Spanish Flu virus and nurtured by Hollywood dramas such as 'Outbreak'). | ||
+ | - Creation of 'Artificial Life' | ||
+ | Some of the group expressed fears about scientists 'playing God', explaining their philosophical and religious concerns about the process of creation and the nature of 'living' beings. There was significant confusion as to how exactly 'life' should be defined, where it begins and ends, and what the requisite level of complexity is. Some people vaguely expressed fears that synthetic biology will 'blur' the line between the 'artificial and natural worlds', although did not elaborate on what was meant by this nor why this would be such a negative development. | ||
+ | - Creation of Monopolies | ||
+ | There is some concern that patenting could lead to creation of commercial monopolies and inhibit research. [e.g. BRCA 1 Gene monopoly causing increase in price of testing which could potentially save lives). | ||
+ | - Global Justice | ||
+ | Some of the group expressed worries about the fact that much of the development of synthetic biology and resulting intellectual property is likely to take place in and by extension principally benefit rich, developed nations. Particular examples of this concern which were raised included the possibility of farmers in poor countries becoming dependent on modified crop seeds controlled by large corporations which could extract whatever price they wished for the product, and the possibility of cheap alternatives for manufacture of chemicals such as antimalarial medicine (artemisinin) ensuring that local prodiction of natural equivalent products would no longer be sustained. Generally, this fear is expressed as a concern that technologies which are socially accepted on the premise that they will improve quality of life in less developed countries (golden rice and GM mosquitoes being cited as examples of such projects) may in actual fact benefit only rich Western companies and have no or even a detrimental impact on the lives of those the project was intended to help. | ||
+ | - Lack of Regulation | ||
+ | There is great concern that the development of fast-growing fields such as synthetic biology is 'overtaking' the regulation which is in place to regulate its application and to balance the risks and potential benefits. The possibility of biological warfare programmes is a major worry. A further concern is the possibility of 'garbage biology' (DIY home synthetic biology) may become a more popular, widespread hobby in the future - increased accessibility would make regulations which are in place far more difficult to enforce. | ||
+ | </div> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 458: | Line 511: | ||
+ | <div class="white_news_block"> | ||
- | <a href="https://2014.igem.org/Team:Oxford/ | + | <a href="https://2014.igem.org/Team:Oxford/policy_and_practices"> |
- | <img src="https://static.igem.org/mediawiki/2014/ | + | <img src="https://static.igem.org/mediawiki/2014/3/33/Oxford_P%26P1.png" style="float:left;position:relative; width:12%;" /></a> |
- | < | + | <a href="https://2014.igem.org/Team:Oxford/P&P_environmental_impact"><img src="https://static.igem.org/mediawiki/2014/7/75/Oxford_P%26P2.png" style="float:left;position:relative; width:12%; margin-left:2.66%;" /></a> |
- | < | + | <a href="https://2014.igem.org/Team:Oxford/P&P_environmental_impact"><img src="https://static.igem.org/mediawiki/2014/3/3f/Oxford_P%26P3.png" style="float:left;position:relative; width:12%; margin-left: 2.66%" /></a> |
- | < | + | |
- | |||
+ | <a href="https://2014.igem.org/Team:Oxford/P&P_intellectual_property"><img src="https://static.igem.org/mediawiki/2014/0/00/Oxford_P%26P4.png" style="float:left;position:relative; width:12%;margin-left: 2.66%;" /></a> | ||
+ | <a href="https://2014.igem.org/Team:Oxford/P&P_communication"> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/4/43/Oxford_P%26P5.png" style="float:left;position:relative; width:13%; margin-left: 2.5%" /></a> | ||
+ | <a href="https://2014.igem.org/Team:Oxford/P&P_public_engagement"><img src="https://static.igem.org/mediawiki/2014/3/32/Oxford_P%26P6.png" style="float:left;position:relative; width:12%; margin-left: 2.66%;" /></a> | ||
+ | <a href="https://2014.igem.org/Team:Oxford/P&P_igem_europe"> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/9/92/Oxford_P%26P7.png" style="float:right;position:relative; width:12%;" /></a> | ||
+ | <br><br><br><br><br><br><br><br><br> | ||
+ | </div> | ||
+ | </div> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 501: | Line 556: | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 525: | Line 572: | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 548: | Line 587: | ||
+ | <div id="sponsors" style="height:10%; width:100%;"></div> | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
</div> | </div> | ||
+ | <img id="sidebarblue" src="https://static.igem.org/mediawiki/2014/e/ec/OxigemsidebarBlue.png" style="float:left;position:fixed;margin-left:-250px;height:100%;" /> | ||
+ | <img class="1" src="https://static.igem.org/mediawiki/2014/a/a5/OxigemDotsDCMation.png" style="opacity:0.9;float:left;position:fixed;margin-left:-250px; top:31.6%; height:17.6%;" /> | ||
+ | <img class="2" src="https://static.igem.org/mediawiki/2014/0/06/OxigemDotsinterlab.png" style="opacity:0.9;float:left;position:fixed;margin-left:-250px; top:18.3%; height:15.125%;" /> | ||
+ | <img class="3" src="https://static.igem.org/mediawiki/2014/e/ee/OxigemDotsP%26P.png" style="opacity:0.9;float:left;position:fixed;margin-left:-250px; top:9%; height:12.75%;" /> | ||
+ | <img class="4" src="https://static.igem.org/mediawiki/2014/c/ca/OxigemDotsTeam.png" style="float:left;position:fixed;margin-left:-250px; top:0%; height:12.625%;" /> | ||
+ | <img class="1" src="https://static.igem.org/mediawiki/2014/f/f5/OxigemDotsModelling.png" style="opacity:0.8;float:left;position:fixed;margin-left:-250px; top:50.6%; height:17.75%;" /> | ||
+ | <img class="2" src="https://static.igem.org/mediawiki/2014/8/87/OxigemDotsAchievements.png" style="opacity:0.9;float:left;position:fixed;margin-left:-250px; top:66.45%; height:13.28%;" /> | ||
+ | <img class="3" src="https://static.igem.org/mediawiki/2014/7/7b/OxigemDotsiGEMcomm.png" style="opacity:0.9;float:left;position:fixed;margin-left:-250px; top:78%; height:12.5%;" /> | ||
+ | <img class="4" src="https://static.igem.org/mediawiki/2014/0/0e/OxigemDotsSafety.png" style="float:left;position:fixed;margin-left:-250px; top:88.15%; height:11.9%;" /> | ||
+ | <a href="https://2014.igem.org/Team:Oxford"><img id="sidebarlogo" class="oxigem" src="https://static.igem.org/mediawiki/2014/a/a4/Oxigemsidebarlogo.png" style="float:left;position:fixed;margin-left:-250px; top:42.5%; height:15%;"/></a> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/3/37/OxigemDotModelling.png" style="float:left;position:fixed; top:59.3%; height:4.125%;" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/0/05/OxigemDotAchievements.png" style="float:left;position:fixed; top:71%; height:4%;" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/7/77/OxigemDotiGEMcomm.png" style="float:left;position:fixed; top:81.5%; height:4.375%;" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/2/27/OxigemDotSafety.png" style="float:left;position:fixed; top:93%; height:4.125%;" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/e/e7/OxigemDotDCMation.png" style="float:left;position:fixed; top:37%; height:4.125%;" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/9/94/OxigemDotInterlab.png" style="float:left;position:fixed; top:25%; height:4.125%;" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/1/19/OxigemDotP%26P.png" style="float:left;position:fixed; top:13.5%; height:4.375%;" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/c/cc/OxigemDotTeam.png" style="float:left;position:fixed; top:3%; height:4.375%;" /> | ||
+ | <img id="modelling1" src="https://static.igem.org/mediawiki/2014/9/93/OxigemDotModelling1.png" style="display:none;float:left;position:fixed; top:59.3%; height:4.125%;" /> | ||
+ | <img id="achievements1" src="https://static.igem.org/mediawiki/2014/0/0f/OxigemDotAchievements1.png" style="display:none;float:left;position:fixed; top:71%; height:4%;" /> | ||
+ | <img id="igemcomm1" src="https://static.igem.org/mediawiki/2014/a/a8/OxigemDotiGEMcomm1.png" style="display:none;float:left;position:fixed; top:81.5%; height:4.375%;" /> | ||
+ | <img id="safety1" src="https://static.igem.org/mediawiki/2014/e/ee/OxigemDotSafety1.png" style="display:none;float:left;position:fixed; top:93%; height:4.125%;" /> | ||
+ | <img id="dcmation1" src="https://static.igem.org/mediawiki/2014/d/db/OxigemDotDCMation1.png" style="display:none;float:left;position:fixed; top:37%; height:4.125%;" /> | ||
+ | <img id="interlab1" src="https://static.igem.org/mediawiki/2014/5/52/OxigemDotInterlab1.png" style="display:none;float:left;position:fixed; top:25%; height:4.125%;" /> | ||
+ | <img id="policy1" src="https://static.igem.org/mediawiki/2014/b/bf/OxigemDotP%26P1.png" style="display:none;float:left;position:fixed; top:13.5%; height:4.375%;" /> | ||
+ | <img id="team1" src="https://static.igem.org/mediawiki/2014/c/c5/OxigemDotTeam1.png" style="display:none;float:left;position:fixed; top:3%; height:4.375%;" /> | ||
+ | <a href="#"><img class="heading" id="modelling" src="https://static.igem.org/mediawiki/2014/e/e0/OxigemSidebarModelling.png" style="opacity:0.8;float:left;position:fixed; top:59%; height:4.5%;" /></a> | ||
+ | <a href="#"><img class="heading" id="achievements" src="https://static.igem.org/mediawiki/2014/4/4a/OxigemSidebarAchievements.png" style="opacity:0.75;float:left;position:fixed; top:71%; height:4%;" /></a> | ||
+ | <a href="#"><img class="heading" id="igemcomm" src="https://static.igem.org/mediawiki/2014/8/83/OxigemSidebariGEMcomm.png" style="opacity:0.8;float:left;position:fixed; top:81.1%; height:5.375%;" /></a> | ||
+ | <a href="https://2014.igem.org/Team:Oxford/safety"><img class="heading" id="safety" src="https://static.igem.org/mediawiki/2014/3/3d/OxigemSidebarSafety.png" style="opacity:0.75;float:left;position:fixed; top:92.9%; height:4.375%;" /></a> | ||
+ | <a href="#"><img class="heading" id="dcmation" src="https://static.igem.org/mediawiki/2014/1/18/OxigemSidebarDCMation.png" style="opacity:0.8;float:left;position:fixed; top:36%; height:5.75%;" /></a> | ||
+ | <a href="#"><img class="heading" id="interlab" src="https://static.igem.org/mediawiki/2014/e/e2/OxigemSidebarInterlab.png" style="opacity:0.8;float:left;position:fixed; top:24.4%; height:5.25%;" /></a> | ||
+ | <a href="https://2014.igem.org/Team:Oxford/policy_and_practices"><img class="heading" id="policy" src="https://static.igem.org/mediawiki/2014/7/7b/OxigemSidebarP%26P.png" style="opacity:0.8;float:left;position:fixed; top:13.2%; height:4.875%;" /></a> | ||
+ | <a href="https://2014.igem.org/Team:Oxford/team"><img class="heading" id="team" src="https://static.igem.org/mediawiki/2014/3/3b/OxigemSidebarTeam.png" style="opacity:0.8;float:left;position:fixed; top:3%; height:4.625%;" /></a> | ||
Line 626: | Line 637: | ||
- | + | <img src="https://static.igem.org/mediawiki/2014/6/60/OxigemAchievements2.png" style="position:fixed; display:none; height:4%; top:37%; left:2%;" /> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | <img src="https://static.igem.org/mediawiki/2014/ | + | |
- | + | ||
<div class="iGEMlogo" style="width:6.5%; position:absolute; top:0.7%; right:0.5%; min-width:50px;"> | <div class="iGEMlogo" style="width:6.5%; position:absolute; top:0.7%; right:0.5%; min-width:50px;"> | ||
- | <a href="https://2014.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2014/ | + | <a href="https://2014.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2014/5/56/OxigemiGEMgrey.png" style="width:100%"/></a> |
</div> | </div> | ||
- | <a href="#"><img id="arrowl" src="https://static.igem.org/mediawiki/2014/ | + | <a href="#"><img id="arrowl" src="https://static.igem.org/mediawiki/2014/1/1d/OxigemArrowleft.png" style="position:fixed; width:50px; top:23%;right:0px; opacity:0.6; z-index:4;" /></a> |
- | <div id="grey" style="width: | + | <div id="grey" style="width:190px; position:fixed; top:23%; right:-175px; z-index:4;"> |
<img src="https://static.igem.org/mediawiki/2014/0/0d/OxigemGrey.png" style="position:relative;width:100%;" /> | <img src="https://static.igem.org/mediawiki/2014/0/0d/OxigemGrey.png" style="position:relative;width:100%;" /> | ||
- | <a href="#"><img id="arrowr" src="https://static.igem.org/mediawiki/2014/0/03/OxigemArrowr.png" style="position:absolute;width: | + | <a href="#"><img id="arrowr" src="https://static.igem.org/mediawiki/2014/0/03/OxigemArrowr.png" style="position:absolute;width:14%;top:5%;left:10%;"></a> |
<div class="fbicon" style="position:absolute;width:23%; top:20%; left:9%;" onmouseover= | <div class="fbicon" style="position:absolute;width:23%; top:20%; left:9%;" onmouseover= | ||
"iconleft(this)" onmouseout="iconnormal(this)" border="0"><a href="https://www.facebook.com/oxfordigem" target="_blank" style="background-image: none;"><img src="https://static.igem.org/mediawiki/2014/8/88/OxigemIconfacebook.png" style="width:100%;" /></a> | "iconleft(this)" onmouseout="iconnormal(this)" border="0"><a href="https://www.facebook.com/oxfordigem" target="_blank" style="background-image: none;"><img src="https://static.igem.org/mediawiki/2014/8/88/OxigemIconfacebook.png" style="width:100%;" /></a> |
Revision as of 08:09, 20 September 2014
#list li { list-style-image: url("https://static.igem.org/mediawiki/2014/6/6f/OxigemTick.png"); } }
![](https://static.igem.org/mediawiki/2014/e/ec/OxigemsidebarBlue.png)
![](https://static.igem.org/mediawiki/2014/a/a5/OxigemDotsDCMation.png)
![](https://static.igem.org/mediawiki/2014/0/06/OxigemDotsinterlab.png)
![](https://static.igem.org/mediawiki/2014/e/ee/OxigemDotsP%26P.png)
![](https://static.igem.org/mediawiki/2014/c/ca/OxigemDotsTeam.png)
![](https://static.igem.org/mediawiki/2014/f/f5/OxigemDotsModelling.png)
![](https://static.igem.org/mediawiki/2014/8/87/OxigemDotsAchievements.png)
![](https://static.igem.org/mediawiki/2014/7/7b/OxigemDotsiGEMcomm.png)
![](https://static.igem.org/mediawiki/2014/0/0e/OxigemDotsSafety.png)
![](https://static.igem.org/mediawiki/2014/a/a4/Oxigemsidebarlogo.png)
![](https://static.igem.org/mediawiki/2014/3/37/OxigemDotModelling.png)
![](https://static.igem.org/mediawiki/2014/0/05/OxigemDotAchievements.png)
![](https://static.igem.org/mediawiki/2014/7/77/OxigemDotiGEMcomm.png)
![](https://static.igem.org/mediawiki/2014/2/27/OxigemDotSafety.png)
![](https://static.igem.org/mediawiki/2014/e/e7/OxigemDotDCMation.png)
![](https://static.igem.org/mediawiki/2014/9/94/OxigemDotInterlab.png)
![](https://static.igem.org/mediawiki/2014/1/19/OxigemDotP%26P.png)
![](https://static.igem.org/mediawiki/2014/c/cc/OxigemDotTeam.png)
![](https://static.igem.org/mediawiki/2014/e/e0/OxigemSidebarModelling.png)
![](https://static.igem.org/mediawiki/2014/4/4a/OxigemSidebarAchievements.png)
![](https://static.igem.org/mediawiki/2014/8/83/OxigemSidebariGEMcomm.png)
![](https://static.igem.org/mediawiki/2014/3/3d/OxigemSidebarSafety.png)
![](https://static.igem.org/mediawiki/2014/1/18/OxigemSidebarDCMation.png)
![](https://static.igem.org/mediawiki/2014/e/e2/OxigemSidebarInterlab.png)
![](https://static.igem.org/mediawiki/2014/7/7b/OxigemSidebarP%26P.png)
![](https://static.igem.org/mediawiki/2014/3/3b/OxigemSidebarTeam.png)
![](https://static.igem.org/mediawiki/2014/1/1d/OxigemArrowleft.png)